NVAX logo

Novavax, Inc. (NVAX) Revenue

Annual revenue:

$682.16M-$301.54M(-30.65%)
December 31, 2024

Summary

  • As of today (August 31, 2025), NVAX annual revenue is $682.16 million, with the most recent change of -$301.54 million (-30.65%) on December 31, 2024.
  • During the last 3 years, NVAX annual revenue has fallen by -$464.13 million (-40.49%).
  • NVAX annual revenue is now -65.58% below its all-time high of $1.98 billion, reached on December 31, 2022.

Performance

NVAX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Quarterly revenue:

$239.24M-$427.42M(-64.11%)
June 30, 2025

Summary

  • As of today (August 31, 2025), NVAX quarterly revenue is $239.24 million, with the most recent change of -$427.42 million (-64.11%) on June 30, 2025.
  • Over the past year, NVAX quarterly revenue has dropped by -$176.24 million (-42.42%).
  • NVAX quarterly revenue is now -67.43% below its all-time high of $734.58 million, reached on September 30, 2022.

Performance

NVAX Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

TTM revenue:

$1.08B-$176.24M(-14.04%)
June 30, 2025

Summary

  • As of today (August 31, 2025), NVAX TTM revenue is $1.08 billion, with the most recent change of -$176.24 million (-14.04%) on June 30, 2025.
  • Over the past year, NVAX TTM revenue has increased by +$91.05 million (+9.22%).
  • NVAX TTM revenue is now -45.57% below its all-time high of $1.98 billion, reached on December 31, 2022.

Performance

NVAX TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

NVAX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-30.6%-42.4%+9.2%
3 y3 years-40.5%+28.7%-16.4%
5 y5 years+3555.3%+573.2%+2047.2%

NVAX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-65.6%at low-67.4%+195.5%-45.6%+58.1%
5 y5-year-65.6%+3555.3%-67.4%+573.2%-45.6%+2047.2%
alltimeall time-65.6%>+9999.0%-67.4%>+9999.0%-45.6%>+9999.0%

NVAX Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$239.24M(-64.1%)
$1.08B(-14.0%)
Mar 2025
-
$666.65M(+654.9%)
$1.25B(+84.0%)
Dec 2024
$682.16M(-30.7%)
$88.31M(+4.5%)
$682.16M(-22.9%)
Sep 2024
-
$84.51M(-79.7%)
$885.19M(-10.4%)
Jun 2024
-
$415.48M(+342.7%)
$987.67M(-0.9%)
Mar 2024
-
$93.86M(-67.8%)
$996.61M(+1.3%)
Dec 2023
$983.71M(-50.4%)
$291.34M(+55.8%)
$983.71M(-6.3%)
Sep 2023
-
$186.99M(-55.9%)
$1.05B(-34.3%)
Jun 2023
-
$424.43M(+424.3%)
$1.60B(+17.6%)
Mar 2023
-
$80.95M(-77.3%)
$1.36B(-31.4%)
Dec 2022
$1.98B(+72.9%)
$357.40M(-51.3%)
$1.98B(+7.3%)
Sep 2022
-
$734.58M(+295.1%)
$1.85B(+43.0%)
Jun 2022
-
$185.93M(-73.6%)
$1.29B(-8.0%)
Mar 2022
-
$703.97M(+216.8%)
$1.40B(+22.4%)
Dec 2021
$1.15B(+141.0%)
$222.20M(+24.2%)
$1.15B(-4.8%)
Sep 2021
-
$178.84M(-40.0%)
$1.20B(+1.8%)
Jun 2021
-
$298.02M(-33.4%)
$1.18B(+28.5%)
Mar 2021
-
$447.23M(+59.9%)
$919.45M(+93.3%)
Dec 2020
$475.60M(+2448.5%)
$279.66M(+78.1%)
$475.60M(+132.3%)
Sep 2020
-
$157.02M(+341.8%)
$204.75M(+307.6%)
Jun 2020
-
$35.54M(+952.4%)
$50.24M(+178.2%)
Mar 2020
-
$3.38M(-61.7%)
$18.06M(-3.2%)
Dec 2019
$18.66M(-45.6%)
$8.82M(+251.7%)
$18.66M(+16.8%)
Sep 2019
-
$2.51M(-25.3%)
$15.97M(-24.7%)
Jun 2019
-
$3.36M(-15.7%)
$21.20M(-25.9%)
Mar 2019
-
$3.98M(-35.0%)
$28.62M(-16.5%)
Dec 2018
$34.29M(+10.0%)
$6.13M(-20.8%)
$34.29M(-11.1%)
Sep 2018
-
$7.74M(-28.2%)
$38.57M(-1.6%)
Jun 2018
-
$10.77M(+11.6%)
$39.19M(+11.5%)
Mar 2018
-
$9.65M(-7.3%)
$35.15M(+12.7%)
Dec 2017
$31.18M(+103.1%)
$10.41M(+24.7%)
$31.18M(+19.2%)
Sep 2017
-
$8.35M(+24.1%)
$26.16M(+24.3%)
Jun 2017
-
$6.73M(+18.5%)
$21.04M(+25.1%)
Mar 2017
-
$5.68M(+5.2%)
$16.82M(+9.5%)
Dec 2016
$15.35M(-57.6%)
$5.40M(+67.1%)
$15.35M(-2.9%)
Sep 2016
-
$3.23M(+29.0%)
$15.81M(-17.2%)
Jun 2016
-
$2.50M(-40.6%)
$19.10M(-37.6%)
Mar 2016
-
$4.22M(-27.9%)
$30.59M(-15.6%)
Dec 2015
$36.25M(+18.2%)
$5.85M(-10.3%)
$36.25M(-2.3%)
Sep 2015
-
$6.53M(-53.4%)
$37.12M(-4.4%)
Jun 2015
-
$14.00M(+41.7%)
$38.81M(+17.3%)
Mar 2015
-
$9.88M(+46.9%)
$33.07M(+7.9%)
Dec 2014
$30.66M(+46.6%)
$6.72M(-18.1%)
$30.66M(-6.2%)
Sep 2014
-
$8.21M(-0.5%)
$32.68M(+11.7%)
Jun 2014
-
$8.26M(+10.7%)
$29.27M(+19.3%)
Mar 2014
-
$7.46M(-14.7%)
$24.54M(+17.4%)
Dec 2013
$20.91M(-5.3%)
$8.75M(+82.2%)
$20.91M(+25.0%)
Sep 2013
-
$4.80M(+36.0%)
$16.73M(-5.4%)
Jun 2013
-
$3.53M(-7.9%)
$17.70M(-16.8%)
Mar 2013
-
$3.83M(-16.1%)
$21.27M(-3.7%)
Dec 2012
$22.08M(+50.3%)
$4.57M(-20.8%)
$22.08M(-5.5%)
Sep 2012
-
$5.76M(-18.8%)
$23.36M(+3.3%)
Jun 2012
-
$7.10M(+53.0%)
$22.60M(+22.2%)
Mar 2012
-
$4.64M(-20.6%)
$18.50M(+25.9%)
Dec 2011
$14.69M(+4182.2%)
$5.84M(+16.7%)
$14.69M(+65.1%)
Sep 2011
-
$5.01M(+66.9%)
$8.89M(+119.0%)
Jun 2011
-
$3.00M(+259.8%)
$4.06M(+280.6%)
Mar 2011
-
$834.00K(+1535.3%)
$1.07M(+211.1%)
Dec 2010
$343.00K
$51.00K(-70.9%)
$343.00K(-6.5%)
DateAnnualQuarterlyTTM
Sep 2010
-
$175.00K(+2400.0%)
$367.00K(-6.6%)
Jun 2010
-
$7000.00(-93.6%)
$393.00K(-5.3%)
Mar 2010
-
$110.00K(+46.7%)
$415.00K(+27.3%)
Dec 2009
$325.00K(-69.5%)
$75.00K(-62.7%)
$326.00K(+1.6%)
Sep 2009
-
$201.00K(+593.1%)
$321.00K(+2.2%)
Jun 2009
-
$29.00K(+38.1%)
$314.00K(-49.9%)
Mar 2009
-
$21.00K(-70.0%)
$627.00K(-41.1%)
Dec 2008
$1.06M(-26.9%)
$70.00K(-63.9%)
$1.06M(-23.5%)
Sep 2008
-
$194.00K(-43.3%)
$1.39M(-44.6%)
Jun 2008
-
$342.00K(-25.3%)
$2.51M(+7.9%)
Mar 2008
-
$458.00K(+15.7%)
$2.33M(-8.3%)
Dec 2007
$1.46M(-68.9%)
$396.00K(-69.9%)
$2.54M(-27.3%)
Sep 2007
-
$1.31M(+732.3%)
$3.49M(+3.6%)
Jun 2007
-
$158.00K(-76.3%)
$3.37M(-16.8%)
Mar 2007
-
$668.00K(-50.4%)
$4.05M(-13.6%)
Dec 2006
$4.68M(-36.6%)
$1.35M(+13.0%)
$4.68M(-16.1%)
Sep 2006
-
$1.19M(+42.2%)
$5.58M(-10.8%)
Jun 2006
-
$839.00K(-35.6%)
$6.25M(-19.1%)
Mar 2006
-
$1.30M(-41.9%)
$7.73M(+4.6%)
Dec 2005
$7.39M(-10.6%)
$2.24M(+20.2%)
$7.39M(+2.8%)
Sep 2005
-
$1.87M(-19.4%)
$7.19M(+9.0%)
Jun 2005
-
$2.31M(+140.6%)
$6.59M(-9.5%)
Mar 2005
-
$962.00K(-53.0%)
$7.29M(-23.7%)
Dec 2004
$8.26M(-29.9%)
$2.05M(+60.8%)
$9.54M(-17.3%)
Sep 2004
-
$1.27M(-57.7%)
$11.54M(-20.6%)
Jun 2004
-
$3.00M(-6.7%)
$14.54M(+5.3%)
Mar 2004
-
$3.22M(-20.4%)
$13.81M(+17.2%)
Dec 2003
$11.79M(-21.5%)
$4.05M(-5.2%)
$11.79M(+15.1%)
Sep 2003
-
$4.27M(+87.6%)
$10.24M(+21.4%)
Jun 2003
-
$2.27M(+90.5%)
$8.44M(-22.7%)
Mar 2003
-
$1.19M(-52.2%)
$10.90M(-31.0%)
Dec 2002
$15.01M(-24.8%)
$2.50M(+1.3%)
$15.80M(-18.6%)
Sep 2002
-
$2.47M(-48.0%)
$19.42M(-11.7%)
Jun 2002
-
$4.75M(-22.1%)
$21.99M(-12.7%)
Mar 2002
-
$6.09M(-0.4%)
$25.19M(+4.7%)
Dec 2001
$19.94M(+705.7%)
$6.12M(+21.4%)
$24.07M(+28.3%)
Sep 2001
-
$5.04M(-36.6%)
$18.76M(+33.1%)
Jun 2001
-
$7.95M(+60.0%)
$14.09M(+109.3%)
Mar 2001
-
$4.97M(+515.4%)
$6.73M(+172.0%)
Dec 2000
$2.48M(+109.6%)
$807.00K(+118.1%)
$2.48M(+4.1%)
Sep 2000
-
$370.00K(-37.1%)
$2.38M(+10.6%)
Jun 2000
-
$588.00K(-17.2%)
$2.15M(+18.5%)
Mar 2000
-
$710.00K(0.0%)
$1.81M(+53.7%)
Dec 1999
$1.18M(+73.4%)
$710.00K(+396.5%)
$1.18M(+87.9%)
Sep 1999
-
$143.00K(-43.3%)
$628.60K(-8.1%)
Jun 1999
-
$252.00K(+231.6%)
$684.30K(+23.9%)
Mar 1999
-
$76.00K(-51.8%)
$552.40K(-18.9%)
Dec 1998
$681.00K(+31.0%)
$157.60K(-20.7%)
$681.10K(-17.3%)
Sep 1998
-
$198.70K(+65.4%)
$823.50K(+13.6%)
Jun 1998
-
$120.10K(-41.3%)
$724.80K(+2.9%)
Mar 1998
-
$204.70K(-31.8%)
$704.70K(+17.4%)
Dec 1997
$519.70K(+836.4%)
$300.00K(+200.0%)
$600.00K(+100.0%)
Sep 1997
-
$100.00K(0.0%)
$300.00K(0.0%)
Jun 1997
-
$100.00K(0.0%)
$300.00K(0.0%)
Mar 1997
-
$100.00K(0.0%)
$300.00K(0.0%)
Dec 1996
$55.50K(-79.3%)
-
-
Sep 1996
-
$100.00K(0.0%)
$300.00K(+50.0%)
Jun 1996
-
$100.00K(0.0%)
$200.00K(+100.0%)
Mar 1996
-
$100.00K
$100.00K
Dec 1995
$268.00K
-
-

FAQ

  • What is Novavax, Inc. annual revenue?
  • What is the all time high annual revenue for Novavax, Inc.?
  • What is Novavax, Inc. annual revenue year-on-year change?
  • What is Novavax, Inc. quarterly revenue?
  • What is the all time high quarterly revenue for Novavax, Inc.?
  • What is Novavax, Inc. quarterly revenue year-on-year change?
  • What is Novavax, Inc. TTM revenue?
  • What is the all time high TTM revenue for Novavax, Inc.?
  • What is Novavax, Inc. TTM revenue year-on-year change?

What is Novavax, Inc. annual revenue?

The current annual revenue of NVAX is $682.16M

What is the all time high annual revenue for Novavax, Inc.?

Novavax, Inc. all-time high annual revenue is $1.98B

What is Novavax, Inc. annual revenue year-on-year change?

Over the past year, NVAX annual revenue has changed by -$301.54M (-30.65%)

What is Novavax, Inc. quarterly revenue?

The current quarterly revenue of NVAX is $239.24M

What is the all time high quarterly revenue for Novavax, Inc.?

Novavax, Inc. all-time high quarterly revenue is $734.58M

What is Novavax, Inc. quarterly revenue year-on-year change?

Over the past year, NVAX quarterly revenue has changed by -$176.24M (-42.42%)

What is Novavax, Inc. TTM revenue?

The current TTM revenue of NVAX is $1.08B

What is the all time high TTM revenue for Novavax, Inc.?

Novavax, Inc. all-time high TTM revenue is $1.98B

What is Novavax, Inc. TTM revenue year-on-year change?

Over the past year, NVAX TTM revenue has changed by +$91.05M (+9.22%)
On this page